Follow
Nico Callewaert
Nico Callewaert
Professor, Ghent University. Director, VIB-UGent Center for Medical Biotechnology
Verified email at vib-ugent.be
Title
Cited by
Year
Means and methods for single molecule peptide sequencing
N Callewaert, S Eyckerman, S Devos
US Patent 12,019,076, 2024
2024
THU-102-YI Specific glycomic profiles can identify patients at risk of poor transplant-free survival in primary biliary cholangitis
N Somers, N Gatselis, MC van Hooff, V Lygoura, E Butaye, L Grossar, ...
Journal of Hepatology 80, S311, 2024
2024
THU-463 Pre-treatment serum N-glycans predict poor immunotherapy response and survival in hepatocellular carcinoma
N Somers, T Holtmann, F Artusa, E Butaye, L Grossar, S Raevens, ...
Journal of Hepatology 80, S442-S443, 2024
2024
A fast, affordable and minimally-invasive diagnostic test for Cancer of Unknown Primary (CUP) using DNA methylation profiling
J De Wilde, R Van Paemel, A De Koker, S Roelandt, S Van de Velde, ...
Laboratory Investigation, 102091, 2024
2024
The Association between Urine N-Glycome and Prognosis after Initial Therapy for Primary Prostate Cancer
T Vermassen, N Lumen, C Van Praet, N Callewaert, J Delanghe, S Rottey
Biomedicines 12 (5), 1039, 2024
2024
Means and methods for oral protein delivery
N Callewaert, R Vanluchene, B Laukens, A Depicker, V Virdi
US Patent 11,964,002, 2024
2024
Sarbecovirus binders
X Saelens, D De Vlieger, I Rossey, DE Sieglinde, K Sedeyn, L Van Schie, ...
US Patent App. 18/275,986, 2024
2024
OPENPichia: licence-free Komagataella phaffii chassis strains and toolkit for protein expression
K Claes, D Van Herpe, R Vanluchene, C Roels, B Van Moer, E Wyseure, ...
Nature Microbiology 9 (3), 864-876, 2024
22024
Glycosylation of variable immunoglobulin domains
N Callewaert, B Laukens, L Van Schie, W Van Breedam, W Nerinckx
US Patent 11,891,451, 2024
2024
Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted
DD Acar, W Witkowski, M Wejda, R Wei, T Desmet, B Schepens, ...
EBioMedicine 100, 2024
12024
Yeast-based production platform for potent and stable heavy chain-only antibodies
C Lonigro, H Eeckhaut, RA Symakani, K Roose, B Schepens, K Sedeyn, ...
bioRxiv, 2024.03. 04.580093, 2024
2024
Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma
E Butaye, N Somers, L Grossar, N Pauwels, S Lefere, L Devisscher, ...
Alimentary Pharmacology & Therapeutics 59 (1), 23-38, 2024
22024
Validation of a glycomics-based test associated with risk of HCC development in cirrhosis
X Verhelst, L Meuris, R Colman, A Geerts, A Van Hecke, ...
medRxiv, 2024.02. 27.24303387, 2024
2024
GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
L van Schie, W Van Breedam, C Roels, B Schepens, M Frank, ...
MAbs 15 (1), 2210709, 2023
22023
A metabolic gene survey pinpoints fucosylation as a key pathway underlying the suppressive function of regulatory T cells in cancer
S Pinioti, H Sharma, NC Flerin, Q Yu, A Tzoumpa, S Trusso Cafarello, ...
Cancer immunology research 11 (12), 1611-1629, 2023
22023
Modulating antibody effector functions by Fc glycoengineering
M García-Alija, B Van Moer, DE Sastre, T Azzam, JJ Du, B Trastoy, ...
Biotechnology Advances 67, 108201, 2023
62023
Corona virus binders
B Schepens, X Saelens, N Callewaert, D De Vlieger, L Van Schie, ...
US Patent App. 17/760,300, 2023
2023
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
S De Cae, I Van Molle, L van Schie, SR Shoemaker, J Deckers, N Debeuf, ...
bioRxiv, 2023.03. 10.531533, 2023
22023
Tools and methods for expression of membrane proteins
J Steyaert, NLM Callewaert, T Laeremans, E Pardon, K Vandewalle, ...
US Patent App. 18/048,946, 2023
2023
Glycomics-based serum markers as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection
N Somers, E Vandekerckhove, A Geerts, H Degroote, S Lefere, ...
Acta Clinica Belgica 78 (2), 96-102, 2023
42023
The system can't perform the operation now. Try again later.
Articles 1–20